H.R. 4307 · 118th Congress (2023–2025)
Medical Supply Chain Resiliency Act
This bill authorizes actions to facilitate trade in medical goods (i.e., medical devices, pharmaceutical goods, or inputs for such devices or goods).
Specifically, the bill authorizes the President to (1) negotiate, enter into, and enforce a trusted trade partner agreement with a country or countries with respect to medical goods; and (2) proclaim a modification of any existing duty, a continuance of existing duty-free or excise treatment, or additional duties to carry out the trade agreement. These actions may only be taken if the President determines, based on specified considerations, that the reciprocal elimination of existing duties or other import restrictions with respect to medical goods would contribute to U.S. national security and public health.
A trusted trade partner agreement may include certain provisions, such as those to (1) reduce or eliminate duties, quotas, or other trade barriers; (2) diversify and expand supplier networks to secure a reliable supply of medical goods; and (3) harmonize regulatory procedures.
Not later than 60 days before initiating negotiations with a trusted trade partner, the President must submit written notice to Congress. The bill requires congressional consultation and review of these trade agreements. A trade agreement shall not take effect if, during the required review period, Congress enacts a joint resolution of disapproval.
The Office of the U.S. Trade Representative must monitor compliance by a trusted trade partner with the trade agreement's commitments and obligations. Further, the President may take certain actions in response to a failure to comply.
Show official title
To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Trade
This bill’s path
This is H.R. 4307’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Michelle Steel (R-CA-45)
- Cosponsors
7 cosponsors
1 original · 6 later
3 R · 4 D
- Rep. Bradley Scott Schneider (D-IL-10)· Original · Jun 22, 2023
- Rep. Nicole Malliotakis (R-NY-11)· Later · Apr 23, 2024
- Rep. Deborah K. Ross (D-NC-2)· Later · Apr 23, 2024
- Rep. Donald G. Davis (D-NC-1)· Later · May 6, 2024
- Rep. Mike Kelly (R-PA-16)· Later · May 6, 2024
- Rep. Carol D. Miller (R-WV-1)· Later · May 6, 2024
- Rep. Josh Gottheimer (D-NJ-5)· Later · May 14, 2024
- Policy area
- Foreign Trade and International Finance
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jun 22, 2023 – Dec 17, 2024
Referred to committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Trade
Referred to the Subcommittee on Trade.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Trade → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Medical Supply Chain Resiliency Act
Display title, Short title · Introduced in House
To authorize the President to enter into trade agreements for the reciprocal elimination of duties or other import restrictions with respect to medical goods to contribute to the national security and public health of the United States, and for other purposes.
Official title · Introduced in House